The subcutaneous ICD (S-ICD), besides its wide adoption in the above-described setting [80], is a valid therapy also in ICM, since it does not enter the thorax or pleural space, and therefore limits the risk of bleeding that derives from vein access, and pocket hematoma. As S-ICD is...